top
Please input keywords
Order
*Country
日本
アメリカ
中国
オーストラリア
シンガポール
イギリス
フランス
ドイツ
スイス
イタリア
カナダ
韓国
オランダ
ベルギー
スウェーデン
その他
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-luc Daudi
Common name

 B-luc Daudi

Catalog number      310677
Aliases


Disease  Burkitt's lymphoma
Organism
Human 
Strain  Human
Tissue types

Lymphoma

Tissue

Generation of gene editing Daudi and expression analysis

from clipboard

Gene targeting strategy for B-luc Daudi. The luciferase cDNA sequence with CAG promoter was inserted in the AAVS1 locus  exon1 of  wild-type Daudi .


Phenotypic Analysis

from clipboard

The luminescence signal intensity of B-luc Daudi cells. The luminescence intensity was detected by Bright-GloTM luciferase Assay System (Promega, Cat E2610). B-luc Daudi cells have strong luminescence signal.


Tumor Growth Curve & Body Weight Changes

from clipboard

Subcutaneous xenograft tumor growth of B-luc Daudi cells. B-luc Daudi cells and wild-type Daudi cells (5x106) were subcutaneously implanted into the B-NDG mice (n=5).Tumor size and mice body weight were measured twice a week. (A) Tumor average volume ± SEM, (B) Mice body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5a X b2, where a and b were the long and short diameters of the tumor, respectively. As shown in panel A, B-luc Daudi were able to establish tumor in vivo and can be used for efficacy study.


In vivo  Imaging Analysis


from clipboard

from clipboard

A.B-luc Daudi cells were inoculated into the tail vein of B-NDG mice, and imaging was performed on days 0, 3, 7, 10, 14, 17, 21, 24, and 28 for detection and tumor imaging signal intensity analysis

B.Animal weight monitoring after B-NDG mice were inoculated with B-luc Daudi cells.

Results: B-luc Daudi cells were able to establish tumor model steadily and  track tumor volume effectively .